Back to top

WVE Maintains Rating by B. Riley Securities -- Price Target Lowered to $22

WVE Maintains Rating by B. Riley Securities -- Price Target Lowered to $22

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

WAVE Life Sciences Ltd. (WVE)